This study aims to investigate the possible intercellular transfer of wtEGFR protein via exosomes to mutEGFR NSCLC cells and subsequently activates PI3K/AKT and MAPK signaling pathways and triggers cell resistance to osimertinib. The gene discussed is AKT1; the disease is non-small cell lung carcinoma.